Sientra shares soar as earnings beat expectations

You are here: Home > Biotech > Current Article

Sientra shares soar as earnings beat expectations

By Staff Report / Thursday, November 7th, 2019 / Comments Off on Sientra shares soar as earnings beat expectations

Goleta breast implant developer Sientra announced plans to streamline its miraDry operations and acquire its Opus brand manufacturer from Lubrizol Life Science for $20 million in cash. In an accompanying earnings statement, the company also hiked up its guidance for the year after a quarter in which sales rose 33 percent and net losses beat…

This article is only available to Business Times subscribers

Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
Check the STATUS of your Subscription Account.